ÀÏÀß·¯Ã¤¿ë°ü
ä¿ëÁ¤º¸
ÀÎÀç°Ë»ö
±³À°Á¤º¸
ÇìµåÇåÆÃ
½º¸¶Æ®Å¸¿î
ȸ¿ø¼­ºñ½º
À̷¼­ µî·Ï
ä¿ë°ø°í µî·Ï

Medical Project Manager (CRA)

¾÷Á¾ ÀÇ·á/Á¦¾à/°Ç°­ ÀÚº»±Ý
±â¾÷ÇüÅ ¿Ü±¹±â¾÷ ¸ÅÃâÇöȲ
´ëÇ¥ÀÚ »ç¿ø¼ö
ȸ»çÁÖ¼Ò ¼­¿ï µ¿ÀÛ±¸ ½Å´ë¹æ2µ¿ »ï¼ºº¸¶ó¸Å¿È´ÏŸ¿ö 6Ãþ
  • ÇöÀç ä¿ëÁ¤º¸¸¦ º¹»çÇÕ´Ï´Ù.
  • ÇöÀç ä¿ëÁ¤º¸¸¦ ÇÁ¸°ÆÃÇÕ´Ï´Ù.




Á÷Á¾ °æ¿µ¡¤±âȹ¡¤Àü·«, »ç¹«¡¤Ãѹ«¡¤¹ý¹«
±Ù¹«ÇüÅ °è¾àÁ÷ ä¿ëÁ÷±Þ -
¸ðÁýÀοø 0 ¸í ³ªÀÌ Á¦ÇѾøÀ½
°æ·Â °æ·Â ±Þ¿©Á¶°Ç ´ç»ç±ÔÁ¤
Çз ´ëÁ¹ ÀÌ»ó Á¢¼ö±â°£ Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù
 [ȨÆäÀÌÁöÁ¢¼ö]

Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù

* ´ã´ç¾÷¹«
»ó¼¼Á¶°Ç

¡Ü ¸ðÁýºÎ¼­

   ¡Û Medical




¡Ü
Á¢¼ö±â°£ ¹× Á¢¼ö¹æ¹ý


   ¡Û Á¢¼ö±â°£

      - 2014³â 01¿ù 21ÀÏ (È­) ~ 2014³â 02¿ù 03ÀÏ (¿ù) ±îÁö

   ¡Û Á¢¼ö¹æ¹ý

      - ´ç»ç ȨÆäÀÌÁö Á¢¼ö ÀÌ¿ë




¡Ü
¾÷¹«°³¿ä


  ¡Û Manages phase IV studies including PMS as a Project Manager

  ¡Û Maintains timely and effective communication among team members, CRO and site staff. Routinely anticipates/

      identifies potential issues and implements corrective actions independently. Keeps project leadership apprised

      of team issues, seeking guidance as needed. Demonstrates effective conflict resolution

  ¡Û Responsible for site management and site staff performance including: monitors all types of clinical studies

      participates in all types of site visits assures compliance with all protocol requirements assures effective

      patient identification and recruitment plan is in place assures timely reporting of Adverse Events (AEs)/

      Serious Adverse Events (SAEs) and protocol violations ensures proper storage, dispensation, and accountability

      of all Investigational Product(s) and trial-related materials regularly reviews the status of the contents of the

      site binder exhibits effective time management skills

  ¡Û Organize and attends Investigator meetings. May present materials, as requested. Manages with the preparation

      of study start-up materials and tools, as requested. Attends medical staff meetings, project team meetings,

      teleconference with oversea colleagues, and internal/external clinical training sessions according to the

      project communication, monitoring, and/or training plans

  ¡Û Completes and submits reports according to SOP/Operational Instructions (OI) or local regulations. Maintains

      awareness of key study performance indicators for own sites, e.g. Quality Review Visit Reports, patient

      enrollment, and SAEs. Updates study and patient status information. Tracks Investigator payments/milestones.

      Documents and tracks the resolution of all outstanding site-specific protocol-related issues from visit to visit

  ¡Û Conduct site monitoring (including ICF check, source data verification, CRF/safety reports review, study file

      review, IP accountability check) to ensure that studies are going well in accordance with protocol, GCP,

      relevant guidelines and SOPs.




¡Ü
ÀÀ½ÃÀÚ°Ý

   ¡Û Bachelor¡¯s Degree of University(or equivalent)

   ¡Û Pharmacist or nurse or major in scientific field is preferred

   ¡Û Over 1 year of relevant healthcare experience including monitoring & site management

   ¡Û Experience in PMS and clinical trial is preferred

   - Effective written and verbal English communication skills

   - Interpersonal, decision-making and issue resolution skills are required

   - Good communication, negotiation and presentation skill

   - IT skills: Microsoft word/Excel/PowerPoint

   - Comprehensive knowledge of clinical development process and relevant regulations

     ¡Ø e.g., GCP, SOP, local regulations

   - Contract Period: till Sep. 30, 2014



* ÀÔ»çÁö¿ø ½Ã Áß¿ä»çÇ×À» ²À üũÇϼ¼¿ä!

* ±Ù¹«È¯°æ
±Ù¹«Áö¿ª : ¼­¿ï
±Þ¿©Á¶°Ç : ´ç»ç±ÔÁ¤
* Á¢¼ö°³¿ä

¿À´Ã¸¶°¨

Á¢¼ö±â°£ÀÌ Áö³µ½À´Ï´Ù

¡á Á¢¼ö±â°£   ¡á ¿À´Ã   ¡á ¸¶°¨

2014. 01

  • ÀÏ
  • ¿ù
  • È­
  • ¼ö
  • ¸ñ
  • ±Ý
  • Åä
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31

2014. 02

  • ÀÏ
  • ¿ù
  • È­
  • ¼ö
  • ¸ñ
  • ±Ý
  • Åä
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
* ´ã´çÀÚ Á¤º¸
¸ðÁý±â°£ÀÌ Áö³­ ä¿ëÁ¤º¸ÀÇ °æ¿ì ´ã´çÁ¤º¸´Â °ø°³µÇÁö ¾Ê½À´Ï´Ù.
ÇöÀç ä¿ëÁ¤º¸¸¦ º¹»çÇÕ´Ï´Ù. ÇöÀç ä¿ëÁ¤º¸¸¦ ÇÁ¸°ÆÃÇÕ´Ï´Ù.

µî·Ï : 2014³â 1¿ù 21ÀÏ (È­) 13:31    ÃÖÁ¾¼öÁ¤ : 2014³â 1¿ù 22ÀÏ (¼ö) 11:08

º» Á¤º¸´Â ¹ÙÀÌ¿¤ÄÚ¸®¾Æ ¿¡¼­ Á¦°øÇÑ ÀÚ·áÀ̸ç, ½ºÄ«¿ìÆ®Àº(´Â) ±× ³»¿ë»óÀÇ ¿À·ù ¹× Áö¿¬, ±× ³»¿ëÀ» ½Å·ÚÇÏ¿© ÃëÇØÁø Á¶Ä¡¿¡ ´ëÇÏ¿© Ã¥ÀÓÀ» ÁöÁö ¾Ê½À´Ï´Ù. º» Á¤º¸´Â ½ºÄ«¿ìÆ®ÀÇ µ¿ÀÇ ¾øÀÌ Àç¹èÆ÷ÇÒ ¼ö ¾ø½À´Ï´Ù.

¢À ½ºÄ«¿ìÆ® ¿¡¼­´Â °ÅÁþ ±¸ÀÎ ±¤°í¿¡ ´ëÇÑ ÇÇÇØ¸¦ ÃÖ¼ÒÈ­ Çϱâ À§ÇÏ¿© ÇãÀ§ ä¿ë°ø°í¿¡ ½Å°íÁ¦µµ¸¦ ½ÃÇàÇϰí ÀÖ½À´Ï´Ù.
°ÅÁþ±¸Àα¤°í¿¡ ´ëÇÑ ±¸Á÷ÀÚÁÖÀÇ»çÇ× ½Å°íÆ÷»ó±ÝÁ¦ ¾È³» ÇãÀ§ ä¿ë°ø°í ½Å°íÇϱâ

±Ù¹«Áö À§Ä¡ º¸±â

±Ù¹«Áö ÁÖ¼Ò

¼­¿ï µ¿ÀÛ±¸ ½Å´ë¹æ2µ¿ »ï¼ºº¸¶ó¸Å¿È´ÏŸ¿ö 6Ãþ

Å©°Ôº¸±â

[ƯÁý±âȹ] ¹ý·ü»ç¹«Á÷

Á÷¾÷µ¸º¸±â

¹ý·ü»ç¹«Á÷À̶õ?º¯..

¸éÁ¢ helper

¸éÁ¢Áú¹®

Àμº ¡Ú¡Ú¡Ú¡Ú
Àû¼º ¡Ú¡Ú¡Ú¡Ú

Special Interview

½ºÆä¼ÈÀÎÅͺä
¹ý·ü »ç¹«Á÷À̶ó´Â ÀÏÀÌ ¾î¶² ÀÏÀÎÁö Àß ¸ð..